Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.
Authors: Waryah C; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia., Cursons J; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia., Foroutan M; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia., Pflueger C; Australian Research Council Centre of Excellence in Plant Energy Biology, School of Molecular Sciences, University of Western Australia, Perth, WA, 6009, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, 6 Verdun St, Perth, WA, 6009, Australia., Wang E; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia., Molania R; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, 3010, Australia., Woodward E; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia., Sorolla A; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia., Wallis C; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia., Moses C; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Evolutionary Neurogenomics, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, XH 1098, The Netherlands., Glas I; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia., Magalhães L; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Postgraduate Program of Genetics and Molecular Biology, Institute of Biological Sciences, Federal University of Pará, Belém, 66075-110, Brazil., Thompson EW; School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, 4000, Australia.; Translational Research Institute, Brisbane, QLD, 4102, Australia., Fearnley LG; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3800, Australia., Chaffer CL; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.; St Vincent's Clinical School, UNSW Medicine, Darlinghurst, NSW, 2010, Australia., Davis M; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, 3010, Australia., Papenfuss AT; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3800, Australia., Redfern A; School of Medicine, University of Western Australia, Perth, WA, 6009, Australia., Lister R; Australian Research Council Centre of Excellence in Plant Energy Biology, School of Molecular Sciences, University of Western Australia, Perth, WA, 6009, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, 6 Verdun St, Perth, WA, 6009, Australia., Esteller M; Josep Carreras Leukemia Research Institute (IJC), Badalona, Barcelona, 08916, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, 28029, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, 08007, Spain., Blancafort P; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.
Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Aug; Vol. 10 (22), pp. e2301802. Date of Electronic Publication: 2023 May 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37217832
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Waryah+C%22">Waryah C</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Cursons+J%22">Cursons J</searchLink>; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Foroutan+M%22">Foroutan M</searchLink>; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Pflueger+C%22">Pflueger C</searchLink>; Australian Research Council Centre of Excellence in Plant Energy Biology, School of Molecular Sciences, University of Western Australia, Perth, WA, 6009, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, 6 Verdun St, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Molania+R%22">Molania R</searchLink>; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Woodward+E%22">Woodward E</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Sorolla+A%22">Sorolla A</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Wallis+C%22">Wallis C</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Moses+C%22">Moses C</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Evolutionary Neurogenomics, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, XH 1098, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Glas+I%22">Glas I</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Magalhães+L%22">Magalhães L</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Postgraduate Program of Genetics and Molecular Biology, Institute of Biological Sciences, Federal University of Pará, Belém, 66075-110, Brazil.<br /><searchLink fieldCode="AU" term="%22Thompson+EW%22">Thompson EW</searchLink>; School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, 4000, Australia.; Translational Research Institute, Brisbane, QLD, 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Fearnley+LG%22">Fearnley LG</searchLink>; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Chaffer+CL%22">Chaffer CL</searchLink>; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.; St Vincent's Clinical School, UNSW Medicine, Darlinghurst, NSW, 2010, Australia.<br /><searchLink fieldCode="AU" term="%22Davis+M%22">Davis M</searchLink>; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Papenfuss+AT%22">Papenfuss AT</searchLink>; Population Health and Immunity Division, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Redfern+A%22">Redfern A</searchLink>; School of Medicine, University of Western Australia, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Lister+R%22">Lister R</searchLink>; Australian Research Council Centre of Excellence in Plant Energy Biology, School of Molecular Sciences, University of Western Australia, Perth, WA, 6009, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, 6 Verdun St, Perth, WA, 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Esteller+M%22">Esteller M</searchLink>; Josep Carreras Leukemia Research Institute (IJC), Badalona, Barcelona, 08916, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, 28029, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, 08007, Spain.<br /><searchLink fieldCode="AU" term="%22Blancafort+P%22">Blancafort P</searchLink>; Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, 6009, Australia.; Centre for Medical Research, University of Western Australia, Perth, WA, 6009, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101664569%22">Advanced science (Weinheim, Baden-Wurttemberg, Germany)</searchLink> [Adv Sci (Weinh)] 2023 Aug; Vol. 10 (22), pp. e2301802. <i>Date of Electronic Publication: </i>2023 May 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WILEY-VCH%22">WILEY-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101664569 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2198-3844 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221983844%22">21983844 </searchLink><i>NLM ISO Abbreviation: </i>Adv Sci (Weinh) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37217832
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/advs.202301802
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2301802
    Titles:
      – TitleFull: Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Waryah C
      – PersonEntity:
          Name:
            NameFull: Cursons J
      – PersonEntity:
          Name:
            NameFull: Foroutan M
      – PersonEntity:
          Name:
            NameFull: Pflueger C
      – PersonEntity:
          Name:
            NameFull: Wang E
      – PersonEntity:
          Name:
            NameFull: Molania R
      – PersonEntity:
          Name:
            NameFull: Woodward E
      – PersonEntity:
          Name:
            NameFull: Sorolla A
      – PersonEntity:
          Name:
            NameFull: Wallis C
      – PersonEntity:
          Name:
            NameFull: Moses C
      – PersonEntity:
          Name:
            NameFull: Glas I
      – PersonEntity:
          Name:
            NameFull: Magalhães L
      – PersonEntity:
          Name:
            NameFull: Thompson EW
      – PersonEntity:
          Name:
            NameFull: Fearnley LG
      – PersonEntity:
          Name:
            NameFull: Chaffer CL
      – PersonEntity:
          Name:
            NameFull: Davis M
      – PersonEntity:
          Name:
            NameFull: Papenfuss AT
      – PersonEntity:
          Name:
            NameFull: Redfern A
      – PersonEntity:
          Name:
            NameFull: Lister R
      – PersonEntity:
          Name:
            NameFull: Esteller M
      – PersonEntity:
          Name:
            NameFull: Blancafort P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2198-3844
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
              Type: main
ResultId 1